APP and Alzheimer disease: The notion that C99 generated independently of AβPP drives AD pathology is strongly supported by the observation that in AD patients C99 accumulates in the disease-affected neurons but not in the regions of the brain not affected by the disease, and that the extent of its accumulation correlates with the severity of cognitive impairment [282,283].